Piazzetta, G.L.; Lobello, N.; Chiarella, E.; Rizzuti, A.; Pelaia, C.; Pelaia, G.; Lombardo, N.
Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab. J. Pers. Med. 2023, 13, 1404.
https://doi.org/10.3390/jpm13091404
AMA Style
Piazzetta GL, Lobello N, Chiarella E, Rizzuti A, Pelaia C, Pelaia G, Lombardo N.
Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab. Journal of Personalized Medicine. 2023; 13(9):1404.
https://doi.org/10.3390/jpm13091404
Chicago/Turabian Style
Piazzetta, Giovanna Lucia, Nadia Lobello, Emanuela Chiarella, Alberta Rizzuti, Corrado Pelaia, Girolamo Pelaia, and Nicola Lombardo.
2023. "Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab" Journal of Personalized Medicine 13, no. 9: 1404.
https://doi.org/10.3390/jpm13091404
APA Style
Piazzetta, G. L., Lobello, N., Chiarella, E., Rizzuti, A., Pelaia, C., Pelaia, G., & Lombardo, N.
(2023). Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab. Journal of Personalized Medicine, 13(9), 1404.
https://doi.org/10.3390/jpm13091404